153 related articles for article (PubMed ID: 33496398)
1. Characteristics of human immunodeficiency virus exposure and predictors of time until access to postexposure prophylaxis: a prospective observational study.
Casalino E; Bouzid D; Antoniol S; Pinto A; Choquet C; Pereira L; Pavlovsky T; Ing V; Yazdanpanah Y; Ghosn J; Ghazali DA
Emergencias; 2021 Feb; 33(1):35-41. PubMed ID: 33496398
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus postexposure prophylaxis for adolescents and children.
Merchant RC; Keshavarz R
Pediatrics; 2001 Aug; 108(2):E38. PubMed ID: 11483848
[TBL] [Abstract][Full Text] [Related]
3. Anti-retroviral Therapy Based HIV Prevention Among a Sample of Men Who Have Sex with Men in Cape Town, South Africa: Use of Post-exposure Prophylaxis and Knowledge on Pre-exposure Prophylaxis.
Hugo JM; Stall RD; Rebe K; Egan JE; De Swardt G; Struthers H; McIntyre JA
AIDS Behav; 2016 Dec; 20(Suppl 3):357-364. PubMed ID: 27631366
[TBL] [Abstract][Full Text] [Related]
4. Consultations for HIV post-exposure prophylaxis before and after health insurance coverage of pre-exposure prophylaxis to a university-based emergency department in Germany.
Böhm L; Jensen BO; Schelzig H; Luedde T; Bernhard M
HIV Res Clin Pract; 2023 Dec; 24(1):2207977. PubMed ID: 37151090
[No Abstract] [Full Text] [Related]
5. Prevention of human immunodeficiency virus and AIDS: postexposure prophylaxis (including health care workers).
Beekmann SE; Henderson DK
Infect Dis Clin North Am; 2014 Dec; 28(4):601-13. PubMed ID: 25287589
[TBL] [Abstract][Full Text] [Related]
6. Australian gay men who have taken nonoccupational postexposure prophylaxis for HIV are in need of effective HIV prevention methods.
Zablotska IB; Prestage G; Holt M; Poynten M; de Wit J; Guy R; Mao L; McAllister J; Grulich AE
J Acquir Immune Defic Syndr; 2011 Dec; 58(4):424-8. PubMed ID: 21857349
[TBL] [Abstract][Full Text] [Related]
7. Seroconversion following nonoccupational postexposure prophylaxis against HIV.
Roland ME; Neilands TB; Krone MR; Katz MH; Franses K; Grant RM; Busch MP; Hecht FM; Shacklett BL; Kahn JO; Bamberger JD; Coates TJ; Chesney MA; Martin JN
Clin Infect Dis; 2005 Nov; 41(10):1507-13. PubMed ID: 16231265
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of postexposure prophylaxis after sexual or injection-drug exposure to human immunodeficiency virus.
Pinkerton SD; Martin JN; Roland ME; Katz MH; Coates TJ; Kahn JO
Arch Intern Med; 2004 Jan; 164(1):46-54. PubMed ID: 14718321
[TBL] [Abstract][Full Text] [Related]
9. Post-exposure prophylaxis for human immunodeficiency virus after sexual assault in a Midwestern U.S. emergency department.
Cherabie JN; Gleason E; Munigala S; Fox B; Trolard A; McCammon C; Hilbert S; Casabar E; Reno H; Liang SY
Am J Emerg Med; 2021 Nov; 49():117-123. PubMed ID: 34102456
[TBL] [Abstract][Full Text] [Related]
10. Non-Occupational HIV Post-exposure Prophylaxis: A 10-Year Retrospective Review of Data Following Sexual Exposure From Yaounde Central Hospital, Cameroon.
Kouanfack C; Meli H; Cumber SN; Bede F; Nkfusai CN; Ijang PY; Wepngong E; Bassong OYM; Nkoum BA
Int J MCH AIDS; 2019; 8(2):138-145. PubMed ID: 31890345
[TBL] [Abstract][Full Text] [Related]
11. Post-exposure prophylaxis: an underutilized biomedical HIV prevention method among gay, bisexual and other men who have sex with men in China.
Hou J; Wu Y; Xie L; Meng S; Fu R; Zheng H; He N; Huang X; Xu J; Meyers K
AIDS Care; 2020 Dec; 32(12):1573-1580. PubMed ID: 32188267
[TBL] [Abstract][Full Text] [Related]
12. Updated US Public Health Service guidelines for the management of occupational exposures to human immunodeficiency virus and recommendations for postexposure prophylaxis.
Kuhar DT; Henderson DK; Struble KA; Heneine W; Thomas V; Cheever LW; Gomaa A; Panlilio AL;
Infect Control Hosp Epidemiol; 2013 Sep; 34(9):875-92. PubMed ID: 23917901
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of postexposure prophylaxis (PEP) against human immunodeficiency virus infection after sexual or injection drug use exposure: the San Francisco PEP Study.
Kahn JO; Martin JN; Roland ME; Bamberger JD; Chesney M; Chambers D; Franses K; Coates TJ; Katz MH
J Infect Dis; 2001 Mar; 183(5):707-14. PubMed ID: 11181146
[TBL] [Abstract][Full Text] [Related]
14. Assessment of adverse events associated with antiretroviral regimens for postexposure prophylaxis for occupational and nonoccupational exposures to prevent transmission of human immunodeficiency virus.
Luque A; Hulse S; Wang D; Shahzad U; Tanzman E; Antenozzi S; Smith B
Infect Control Hosp Epidemiol; 2007 Jun; 28(6):695-701. PubMed ID: 17520543
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis against possible human immunodeficiency virus exposure after nonoccupational needlestick injuries or sexual assaults in children and adolescents.
Babl FE; Cooper ER; Kastner B; Kharasch S
Arch Pediatr Adolesc Med; 2001 Jun; 155(6):680-2. PubMed ID: 11386957
[TBL] [Abstract][Full Text] [Related]
16. Use of HIV pre-exposure prophylaxis among men who have sex with men in England: data from the AURAH2 prospective study.
Hanum N; Cambiano V; Sewell J; Phillips AN; Rodger AJ; Speakman A; Nwokolo N; Asboe D; Gilson R; Clarke A; Miltz AR; Collins S; Lampe FC;
Lancet Public Health; 2020 Sep; 5(9):e501-e511. PubMed ID: 32888443
[TBL] [Abstract][Full Text] [Related]
17. Non-occupational postexposure prophylaxis for HIV: a systematic review.
Bryant J; Baxter L; Hird S
Health Technol Assess; 2009 Feb; 13(14):iii, ix-x, 1-60. PubMed ID: 19236820
[TBL] [Abstract][Full Text] [Related]
18. Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM).
Palich R; Martin-Blondel G; Cuzin L; Le Talec JY; Boyer P; Massip P; Delobel P
Sex Transm Infect; 2017 Nov; 93(7):493-498. PubMed ID: 28739808
[TBL] [Abstract][Full Text] [Related]
19. Post-exposure prophylaxis completion and condom use in the context of potential sexual exposure to HIV.
Gantner P; Allavena C; Duvivier C; Cabie A; Reynes J; Makinson A; Ravaux I; Bregigeon S; Cotte L; Rey D;
HIV Med; 2020 Aug; 21(7):463-469. PubMed ID: 32558205
[TBL] [Abstract][Full Text] [Related]
20. To prescribe, or not to prescribe: decision making in HIV-1 post-exposure prophylaxis.
Scholten M; Suárez I; Platten M; Kümmerle T; Jung N; Wyen C; Ernst A; Horn C; Burst V; Suárez V; Rybniker J; Fätkenheuer G; Lehmann C
HIV Med; 2018 Oct; 19(9):645-653. PubMed ID: 29993176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
